<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">397520298</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180308164630.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">161202e199512  xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1093/heapol/10.4.404</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)oxford-10.1093/heapol/10.4.404</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Knowledge, attitudes and practices during a community-level ivermectin distribution campaign in Guatemala</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[FRANK O RICHARDS, ROBERT E KLEIN, CARLOS GONZÁLES-PERALTA, RODOLFO ZEA FLORES, SHEILA GONGORA ROMAN, JULIO CASTRO RAMÍREZ, GUILLERMO ZEA FLORES]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Community acceptance and participation are essential for the success of mass ivermectin chemotherapy programmes for onchocerciasis (river blindness). To explore the local understanding of the purpose of ivermectin and willingness to continue taking the drug, we performed questionnaire surveys in four communities with hyperendemic onchocerciasis after each of three ivermectin treatment rounds. More than 100 respondents participated in each KAP survey, representing the heads of 30% of the households in each community. The respondents rarely stated that the goal of the ivermectin treatment programme was to prevent visual loss. Instead, they said they were taking the drug for their general well-being, to cure the onchocercal nodule (filaria), or to cure the microfilaria, a term newly introduced by agents of the treatment programme. The principal reason identified for refusal to take ivermectin was anxiety about drug-related adverse reactions, and there were marked differences between communities in acceptance of treatment. In one community over 50% of residents initially refused to take ivermectin, although participation rates improved somewhat after programmatic adjustments. We recommend that ivermectin distribution programmes establish surveillance activities to detect where acceptance is poor, so that timely and community-specific adjustments may be devised to improve participation.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">© Oxford University Press</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Review paper</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">RICHARDS</subfield>
   <subfield code="D">FRANK O.</subfield>
   <subfield code="u">Division of Parasitic Diseases, Centers for Disease Control and Prevention Atlanta, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">KLEIN</subfield>
   <subfield code="D">ROBERT E.</subfield>
   <subfield code="u">Medical Entomology Research and Training Unit, Centers for Disease Control and Prevention Atlanta, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">GONZÁLES-PERALTA</subfield>
   <subfield code="D">CARLOS</subfield>
   <subfield code="u">River Blindness Foundation Texas, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">FLORES</subfield>
   <subfield code="D">RODOLFO ZEA</subfield>
   <subfield code="u">Medical Entomology Research and Training Unit, Centers for Disease Control and Prevention Atlanta, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">ROMAN</subfield>
   <subfield code="D">SHEILA GONGORA</subfield>
   <subfield code="u">Medical Entomology Research and Training Unit, Centers for Disease Control and Prevention Atlanta, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">RAMÍREZ</subfield>
   <subfield code="D">JULIO CASTRO</subfield>
   <subfield code="u">Departamento de Oncocercosis, Ministerio de Salud Pública y Asistencia Social Guatemala</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">FLORES</subfield>
   <subfield code="D">GUILLERMO ZEA</subfield>
   <subfield code="u">Onchocerciasis Elimination Program of the Americas (OEPA) Antigua, Guatemala</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Health Policy and Planning</subfield>
   <subfield code="d">Oxford University Press</subfield>
   <subfield code="g">10/4(1995-12), 404-414</subfield>
   <subfield code="x">0268-1080</subfield>
   <subfield code="q">10:4&lt;404</subfield>
   <subfield code="1">1995</subfield>
   <subfield code="2">10</subfield>
   <subfield code="o">heapol</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1093/heapol/10.4.404</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">review-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1093/heapol/10.4.404</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">RICHARDS</subfield>
   <subfield code="D">FRANK O.</subfield>
   <subfield code="u">Division of Parasitic Diseases, Centers for Disease Control and Prevention Atlanta, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">KLEIN</subfield>
   <subfield code="D">ROBERT E.</subfield>
   <subfield code="u">Medical Entomology Research and Training Unit, Centers for Disease Control and Prevention Atlanta, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">GONZÁLES-PERALTA</subfield>
   <subfield code="D">CARLOS</subfield>
   <subfield code="u">River Blindness Foundation Texas, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">FLORES</subfield>
   <subfield code="D">RODOLFO ZEA</subfield>
   <subfield code="u">Medical Entomology Research and Training Unit, Centers for Disease Control and Prevention Atlanta, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">ROMAN</subfield>
   <subfield code="D">SHEILA GONGORA</subfield>
   <subfield code="u">Medical Entomology Research and Training Unit, Centers for Disease Control and Prevention Atlanta, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">RAMÍREZ</subfield>
   <subfield code="D">JULIO CASTRO</subfield>
   <subfield code="u">Departamento de Oncocercosis, Ministerio de Salud Pública y Asistencia Social Guatemala</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">FLORES</subfield>
   <subfield code="D">GUILLERMO ZEA</subfield>
   <subfield code="u">Onchocerciasis Elimination Program of the Americas (OEPA) Antigua, Guatemala</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Health Policy and Planning</subfield>
   <subfield code="d">Oxford University Press</subfield>
   <subfield code="g">10/4(1995-12), 404-414</subfield>
   <subfield code="x">0268-1080</subfield>
   <subfield code="q">10:4&lt;404</subfield>
   <subfield code="1">1995</subfield>
   <subfield code="2">10</subfield>
   <subfield code="o">heapol</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">CC BY-NC-4.0</subfield>
   <subfield code="u">http://creativecommons.org/licenses/by-nc/4.0</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-oxford</subfield>
  </datafield>
 </record>
</collection>
